Abstract: A compound for an organic optoelectronic device, a composition for an organic optoelectronic device including the same, an organic optoelectronic device, and a display device, the compound being represented by Chemical Formula 1:

Abstract: A secondary battery includes: an electrode assembly including a first electrode tab and a second electrode tab exposed at opposite sides of the electrode assembly; a case accommodating the electrode assembly and having a side-opening at opposite sides thereof; a first cap plate sealing a one side-opening in the case; a first terminal electrically connected to the first electrode tab, exposed to the outside of the first cap plate, and having a first protrusion that protrudes outwardly; a second cap plate sealing the other side-opening in the case; and a second terminal electrically connected to the second electrode tab, exposed to the outside of the second cap plate, and having a second protrusion that protrudes outwardly. A battery module includes secondary batteries having outer surfaces of the first terminal of one secondary battery and the second terminal of another secondary battery welded to each other.

Abstract: Disclosed herein are an apparatus and method for measuring a railroad of a transfer vehicle to check the installation status of the railroad to ensure that the railroad of the transfer vehicle is installed in accordance with specifications. The apparatus may include a body formed in correspondence with a railroad of the transfer vehicle, a detector provided to the body and arranged in contact with the railroad, and a displacement measurer configured to measure a displacement of the detector in contact with the railroad.

Abstract: The present disclosure relates to a novel citrate synthase variant, a microorganism comprising the variant, and a method for producing L-amino acids using the microorganism.

Abstract: A composition for an organic optoelectronic device an organic optoelectronic device, and a display device, the composition including a first compound; a second compound; and a third compound, wherein the first compound, the second compound, and the third compound are different from each other, the first compound is represented by Chemical Formula I, the second compound is represented by Chemical Formula I, and the third compound is represented by Chemical Formula II or Chemical Formula III:

Abstract: An apparatus for measuring a triglyceride level includes: a sensor including: a plurality of peripheral light sources disposed at a periphery thereof, the plurality of peripheral light sources being configured to emit light toward an object, and a plurality of detectors each disposed at predetermined distances from the respective peripheral light sources of the plurality of peripheral light sources, the plurality of detectors being configured to detect optical signals reflected from or scattered by the object. The apparatus also includes a processor configured to selectively drive the plurality of peripheral light sources to obtain features based on the detected optical signals, and to measure the triglyceride level based on the obtained features.

Abstract: Embodiments of the invention relate to a novel class of polymers with superior mechanical properties and chemical stability, as compared to known polymers. These polymers are particularly well suited for use in anion exchange membranes (AEMs), including those employed in fuel cells. Novel methods for the manufacture of these polymers are also described.

Abstract: Electroencephalography (EEG) data may be analyzed to calculate various metrics such as maximum amplitude projection, node visit frequency, node transition frequency, and/or node transition polarity. The calculated metrics may be provided graphically in some examples. In some examples, the metrics may be provided graphically in combination with other data such as raw EEG traces.

Abstract: A charging cable for an electric vehicle includes a cable main body having a flat cross-section in a width direction thereof and partitioned into a plurality of internal regions. The charging cable includes terminal portions through which positive and negative power cables, a communication/sensor cable, a coolant flow channel, and a ground pass into the plurality of internal regions, respectively. The terminal portions are arranged in a row in the width direction of the cable main body.

Abstract: Provided are apparatuses, a non-transitory computer-readable medium or media, and methods for supporting predicting of vascular disease using a fundus image of a subject. In certain aspects, disclosed a method including the steps of: extracting a feature information from a first fundus image of the subject based on a machine learning model; generating a second fundus image having a feature which is corresponding to the feature information by mapping a saliency factor to the first fundus image; and displaying the first fundus image and the second fundus image on a display device.

Abstract: An apparatus for detecting a body component according to an example embodiment includes: a sensor configured to detect a bio-signal of an object according to a contact pressure that gradually changes between the object and the sensor; and a processor configured to determine a time point, at which an amplitude of an alternating current (AC) component of the bio-signal is maximum or a slope of a direct current (DC) component of the bio-signal is maximum, and to detect a body component of the object based on the determined time point.

Abstract: The present invention relates to a composition for preventing or treating transplantation rejection or a transplantation rejection disease, comprising a novel compound and a calcineurin inhibitor. A co-administration of the present invention 1) reduces the activity of pathogenic Th1 cells or Th17 cells, 2) increases the activity of Treg cells, 3) has an inhibitory effect against side effects, such as tissue damage, occurring in the sole administration thereof, 4) inhibits various pathogenic pathways, 5) inhibits the cell death of inflammatory cells, and 6) increases the activity of mitochondria, in an in vivo or in vitro allogenic model, a transplantation rejection disease model, a skin transplantation model, and a liver-transplanted patient, and thus inhibits transplantation rejection along with mitigating side effects possibly occurring in the administration of a conventional immunosuppressant alone.

Abstract: Disclosed are a dielectric substance-electrode assembly in which an electrode is coated with a dielectric and a method for manufacturing the same. The dielectric substance-electrode assembly is formed by forming a lower dielectric electrode constituting a lower portion of an assembly body, sealing a capsule filled with a treated powder and a lower dielectric in which an electrode is formed, and forming an upper dielectric constituting an upper portion of the assembly body using the treated powder which is diffused on and bonded to surfaces of the lower dielectric and the electrode due to sintering heat treatment which is performed by applying an isostatic pressure in a state in which the sealed capsule is placed in a pressure vessel of a heat treatment equipment.

Abstract: A fusing apparatus includes: a pressing roller to be axially rotated; a fusing belt to rotate by receiving a rotational force from the pressing roller; a pressing member to press toward the pressing roller from the inside of the fusing belt to form a nip in which the printing paper is nipped between the fusing belt and the pressing roller; on the fusing belt or the pressing member, a sliding layer to reduce friction between the fusing belt and the pressing member; and an adhesive layer to adhere the sliding layer to the fusing belt or the pressing member.

Abstract: Provided herein are novel CLDN6 binding domains, and anti-CLDN6×anti-CD3 antibodies that include such CLDN6 binding domains. Also provided herein are methods of using such antibodies for the treatment of CLDN6-associated cancers.

Abstract: The present disclosure relates to a plurality of host materials, an organic electroluminescent compound, and an organic electroluminescent device comprising the same. By comprising a specific combination of host compounds and/or an organic electroluminescent compound according to the present disclosure as an organic electroluminescent material, an organic electroluminescent device having low driving voltage and/or high luminous efficiency and/or long lifespan characteristics can be provided.

Abstract: In an embodiment a method includes manufacturing a membrane-electrode-gas diffusion layer assembly (MEGA) fabric by bonding a gas diffusion layer (GDL) material to a first surface of a membrane-electrode assembly (MEA) fabric, injecting, by a steam injector, a liquid material to a first surface of the MEGA fabric while allowing the liquid material to be absorbed to the first surface of the MEGA fabric, supplying, by a gas injector, compressed gas to a second surface of the MEGA fabric in which the liquid material has been absorbed, inspecting, by a surface inspection device, a surface state of the MEGA fabric after supplying the compressed gas and, after inspecting, winding the MEGA fabric around a MEGA winding unit.

Abstract: The present invention relates to a fluorescent reporter capable of labeling nucleic acids including DNA and exhibiting luminescent properties at an excited energy level, and various uses thereof.

Abstract: Disclosed is an apparatus and method for controlling step charging of a secondary battery. A charging control unit determines a SOC, an OCV and a polarization voltage of the secondary battery, determines an OCV deviation corresponding to a difference between the OCV and a predefined minimum OCV value, determines a correction factor corresponding to the polarization voltage and the OCV deviation, determines a look-up SOC by correcting the SOC according to the correction factor, determines the magnitude of a charging current corresponding to the look-up SOC, and provides the determined charging current to a charging device.